products douglas-laboratories wobenzym-n-400s


By : Douglas Laboratories


Wobenzym® N may be a useful dietary supplement for individuals wishing to support healthy joint, immune and circulatory function.


3 enteric-coated tablets contain:
Pancreatin 56,000 USP units protease ... 300 mg
(pancreas) Sus scrofa
Papain 492 FIP unit* Carica papaya ... 180 mg
Bromelain 675 FIP unit* Ananas comosus ... 135 mg
Trypsin 2160 FIP unit* (pancreas) Sus scrofa ... 72 mg
Chymotrypsin 900 FIP unit* (pancreas) Bos taurus ... 3 mg
Rutoside trihydrate (Rutin) Sophora japonica ... 150 mg

Other ingredients: cellulose, vegetable-based enteric coating, - vegetable stearate, natural vanilla flavour, purified water.


Douglas Laboratories, a leading provider of dietary supple- ments, is proud to offer the authentic German formula of Wobenzym® N. This well known, clinically studied enzyme preparation is designed to promote healthy joints and muscles, support healthy circulation, strengthen the immune system, and support healthy aging.

For over 60 years, Wobenzym® has been a trusted name for enzyme supplementation. Developed by leading scientists and used by millions of people worldwide, Wobenzym® N has proven to be a safe and useful product.In the human body, hundreds of chemical reactions occur dur- ing the course of normal metabolic processes. Many chemical reactions require significant energy in order to take place, and therefore need a catalyst to allow the reaction to proceed. The catalyst acts to lower the energy needed for the reaction to move forward. In the body, enzymes play the role of the cata- lyst and allow reactions to take place that otherwise would not occur. The enzyme itself is not consumed in this process and can be utilized again and again. Enzymes are relatively unique to each reaction and different enzymes will catalyze different reactions. Structurally, enzymes are complex molecules that are comprised of amino acid chains and can sometimes include co-factors which assist the enzyme in the chemical reaction. Some enzymes are sensitive to changes in pH and temperature and can be destroyed if exposed to less than ideal conditions. Wobenzym® N is a systemic enzyme formulation that contains a blend of enzymes from both plants and animals that has been clinically studied for supporting numerous processes in the body. Systemic enzyme supplements work directly in the body once they are absorbed in the small intestine, and are not intended to aid in digestion. Consequently, these enzymes can be utilized to assist the body's various regulatory and commu- nications systems. Wobenzym® N can help to support healthy joints and muscles, support healthy circulation, support the immune system, and also can help support processes that are involved in healthy aging. Wobenzym® N tablets are enteric coated to ensure that the enzymes are protected and are not broken down in the stomach. This allows the enzymes to reach the small intestine where absorption may occur.




Adults take 3 tablets 2 times daily at least 45 minutes before meals or as directed by your healthcare professional.

Potential side effects/Safety


Warning: If you are pregnant or breastfeeding, suffering from bleeding disorders or liver damage, or if you are tak- ing anticoagulant drugs (such as warfarin), consult a health- care professional before using this product.


"Show references"

"Hide references"

Biziulevicius GA. Where do the immunostimulatory effects of oral proteolytic enzymes (systemic enzyme therapy') come from? Microbial proteolysis as a pos- sible starting point. Med Hypotheses. 2006;67(6):1386-8. Epub 2006 Jul 25.
Fediv OI. [Effects of wobenzyme on the blood proteinase-inhibitory system in elderly and senile patients with gastric and duodenal peptic ulcers] [Article in Ukrainian]Lik Sprava. 2001 May-Jun;(3):130-5
Duskov_ M, Wald M. Orally administered proteases in aesthetic surgery. Aesthetic Plast Surg. 1999 Jan-Feb;23(1):41-4.
Hoernecke R, Doenicke A. [Perioperative enzyme therapy. A significant supple- ment to postoperative pain therapy?] [Article in German]Anaesthesist. 1993 Dec;42(12):856-61
Nouza K. [Systemic enzyme therapy in diseases of the vascular system] [Article in Czech]Bratisl Lek Listy. 1995 Oct;96(10):566-9.

Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. © 2015 NDAssist Inc. and/or its affiliates. All rights reserved.